Screening Emotions in Adolescents at the Hospital for mTBI

Part of paid clinical trials in Sacramento, California.

Sponsor
University of California, Davis
Study ID
NCT06370520
Status
Recruiting

Conditions

  • Brain Injuries
  • Brain Injuries, Acute
  • Brain Injury Traumatic Focal With Loss of Consciousness
  • Brain Injury Traumatic Mild
  • Diffuse Axonal Injury
  • Head Injury
  • Head Injury Trauma
  • Head Injury With Intracranial Hemorrhage
  • Intracranial Hemorrhages
  • Skull Fractures

Eligibility Criteria

Sex
ALL
Age
11 Years - 17 Years
Healthy Volunteers
Not accepted

Interventions

  • Validated Questionnaires — BEHAVIORAL
    Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-8 (PHQ-8), The Rivermead Post Concussion Symptom Questionnaire (Rivermead), Pediatric Quality of Life Inventory (PedsQL), Strengths and Difficulties Questionnaire (SDQ)
  • Questionnaires — BEHAVIORAL
    Early Physical Activity/Return to School Questionnaire, Mental Health Utilization Questionnaire
  • Clinician / Medical Record Variables — OTHER
    Medical History, Emergency Department Clinical Variables

Study Details

The goal of this observational study is to develop and validate a clinical tool to predict which adolescents aged 11 to less than 18 years of age with mild traumatic brain injury (mTBI) are at an increased risk for developing significant new or worsening mental health conditions. The main aims the study wish to answer are: * Does the adolescent have new or worsening depression or anxiety defined as a change from their previous medical history using self-reported questionnaires at either one or three months post-injury? * Does the adolescent have unmet mental health care needs, defined as not receiving any mental or behavior health care in patients with new or worsening anxiety or depression as defined by the self reported questionnaires? Participants will be enrolled after being diagnosed in the emergency department (ED) with an mTBI. During the ED visit, the child's parent/caregiver and the adolescent will complete several questionnaires related to mental health which include tools to measure anxiety and depression. Participants will be asked to complete these questionnaires again at 1 month and 3 months post enrollment.

Key Dates

Start date
May 22, 2024
Status verified
Sep 2025
Primary completion
Sep 30, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
2,592 participants (estimated)

Arms

  • Arm: Derivation Cohort
    Four sites will enroll a derivation cohort (n=1512) of head-injured children. Qualified participants will complete or be evaluated with validated questionnaires. Data related to the mTBI event and the participants medical history will be recorded.
  • Arm: Validation Cohort
    Three sites will enroll a validation cohort (n=1080) of head-injured children. Qualified participants will complete or be evaluated with validated questionnaires. Data related to the mTBI event and the participants medical history will be recorded.

Primary Outcome Measure

New or worsening depression or anxiety [ Time Frame: The Generalized Anxiety Disorder-7 (GAD-7) and Patient Health Questionnaire-8 (PHQ-8) are measured at approximately 30 days and approximately 90 days after the emergency department (ED) baseline visit. ]

Central Contacts

Locations (6)

FacilityCityStateZIPSite coordinators
University of California, Davis Medical CenterSacramentoCalifornia95817
Maria Marois, PhD, MPH
916-734-0373
Kyle Pimenta, BAS
916-734-8847
Daniel K Nishijima, MD, MAS (PRINCIPAL_INVESTIGATOR)
Children's Hospital of PhiladelphiaPhiladelphiaPennsylvania19104
Daniel Corwin, MD
215-327-2306
Melissa Godfrey, MPH
302-598-2134
Kristy Arbogast, PhD (PRINCIPAL_INVESTIGATOR)
Hasbro Children's Hospital and Brown UniversityProvidenceRhode Island02903
Stephanie Ruest, MD, MPH
401-606-3532
Mhina Johnbaptiste, MPH
954-591-1222
Stephanie Ruest, MD, MPH (PRINCIPAL_INVESTIGATOR)
University of Texas Southwestern Medical CenterDallasTexas75390
Mohamed Badawy, MD
214-456-7106
Mia Hamilton, MSW
501-701-0239
Mohamad Badawy, MD (PRINCIPAL_INVESTIGATOR)
Baylor College of Medicine, Texas Children's HospitalHoustonTexas77030
Andrea Cruz, MD, MPH
832-824-5582
Victor Gonzalez, MD
832-824-5977
Andrea Cruz, MD, MPH (PRINCIPAL_INVESTIGATOR)
The Medical College of Wisconsin, Inc.MilwaukeeWisconsin53226
Danny G Thomas, MD, MPH
414-266-2625
Najia Ali
414-266-2767
Danny G Thomas, MD, MPH (PRINCIPAL_INVESTIGATOR)

Find similar trials in Sacramento, CA

Related Studies